Search Results - "Marrodan, Ines"
-
1
Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer
Published in PloS one (13-10-2014)“…The biological roles of estrogen receptor 1 (ERS1), estrogen receptor 2 (ERS2), and aromatase (CYP19A1) genes in the development of non-small cell lung cancer…”
Get full text
Journal Article -
2
Fixed-Dose-Rate Gemcitabine Infusion in Patients with Advanced Pancreatic or Biliary Tree Adenocarcinoma
Published in Tumori (01-05-2010)“…Aims and background Gemcitabine is an effective agent in pancreatic adenocarcinoma. Fixed-dose-rate gemcitabine has an interesting biological and clinical…”
Get full text
Journal Article -
3
The influence of carrying BRCA pathogenic mutations in ovarian cancer and its platinum-sensitivity: 5-year experience of a tertiary center
Published in Journal of clinical oncology (01-06-2022)“…e17572 Background: Platinum-based chemotherapy still remains as the backbone treatment in ovarian cancer (OC) and its homologous tumors (primary peritoneal PP…”
Get full text
Journal Article -
4
Bevacizumab (BV) plus irinotecan (I) in recurrent glioblastoma multiforme (GBM): A single center experience
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e13000 Background: Glioblastoma multiforme constitutes the most common and malignant form of primary brain tumor. Median survival for recurrent…”
Get full text
Journal Article -
5
Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) in patients with locally advanced rectal cancer
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e14628 Background: Locally advanced rectal carcinoma is associated with high rate of abdomino-perineal amputation. We analyzed a cohort of…”
Get full text
Journal Article -
6
Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) or capecitabine alone (CAP) in patients (PTS) with locally advanced rectal cancer (LARC)
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e14712 Background: Preoperative concomitant QT-RT has shown to improve sphincter preservation and local control in LARC. We analyzed two cohorts…”
Get full text
Journal Article -
7
Bevacizumab (B), cisplatin (C), and pemetrexed (P) plus maintenance B in chemonaive patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): A phase II study
Published in Journal of clinical oncology (20-05-2012)“…Abstract only e18031 Background: B in combination with platinum doublets followed by continuation maintenance with B prolongs survival and delays progression…”
Get full text
Journal Article -
8
Correlation of increased tumor expression of estrogen receptor alpha mRNA and low aromatase protein ratio with prognosis in resected non-small cell lung cancer (NSCLC)
Published in Journal of clinical oncology (20-05-2012)“…Abstract only e21009 Background: Although several studies have shown the presence of estrogen receptors (ERs) in lung tumors, published reports show…”
Get full text
Journal Article -
9
Adjuvant chemotherapy with cisplatin and gemcitabine in resected non-small cell lung cancer: A single institutional experience
Published in Journal of clinical oncology (20-05-2012)“…Abstract only e17522 Background: Adjuvant chemotherapy in operable non small cell lung cancer (NSCLC) has been shown to improve overall survival in many…”
Get full text
Journal Article -
10
Bevacizumab plus chemotherapy in the treatment of metastatic breast cancer: Hospital of Cruces experience
Published in Journal of clinical oncology (20-05-2012)“…Abstract only e11525 Background: Antiangiogenic therapies such as bevacizumab (BV), have proven to be effective in improving outcomes in metastatic disease…”
Get full text
Journal Article -
11
Elderly patients and ovarian epithelial cancer (OEC) or primary peritoneal carcinoma (PPC): A retrospective analysis
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e20718 Background: OEC frequency in elderly patients is increasing around the world and it’s expected to continue rising in the future. PPC is an…”
Get full text
Journal Article -
12
Estrogen Receptor 1 Gene Expression and Its Combination with Estrogen Receptor 2 or Aromatase Expression Predicts Survival in Non-Small Cell Lung Cancer: e109659
Published in PloS one (01-10-2014)“…The biological roles of estrogen receptor 1 (ERS1), estrogen receptor 2 (ERS2), and aromatase (CYP19A1) genes in the development of non-small cell lung cancer…”
Get full text
Journal Article